Table 1.
14-membered macrolides | 15-membered macrolide | 16-membered macrolides | Lincosamides | S.C. | Ketolide | Tetracycline | Fluoroquinolones | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isolates | ERYa | CLA | AZM | JOS | MDM | RKI | LIN | CLI | Q–D | TEL | MIN | CIP | LEV | MXF |
Sensitive reference strains M129 (ATCC 29342) | 0.004–0.03 | 0.002–0.015 | 0.002–0.06 | 0.03–0.12 | 0.008–0.06 | 0.01–0.06 | 8 | 4 | 0.25 | 0.002 | 0.25 | 1 | 0.12–1 | 0.03–0.25 |
CLINICAL STRAINS WITH MUTATION IN DOMAIN V OF 23S rRNA: | ||||||||||||||
A2058Gb | 32–>256 | 32–>256 | 2–>64 | 0.06–64 | 2–>64 | 0.01–16 | >256 | 16–256 | 0.06–1 | 16–>64 | 0.016–1 | 0.125–2 | 0.125–2 | <0.008–0.03 |
A2058C | >256 | >256 | 16 | 64 | 64 | 4 | 64 | 32 | 1 | NDc | ND | ND | ND | ND |
A2058T | 32–64 | 16–64 | 0.064–0.25 | 16 | ND | 4 | ND | 256 | ND | ND | 0.25–1 | 0.5–1 | 0.25–1 | 0.032 |
A2059G | >64–>256 | 16–>256 | 4–64 | >64–256 | >64–>256 | 8–32 | 64 | 32 | 0.06–0.25 | 1–16 | 0.03–1 | 0.5–1 | 0.25–1 | 0.06–0.12 |
C2611G | 8 | 1 | 0.03 | 0.25 | 0.25 | 0.06 | 16 | 4 | 0.25 | ND | ND | ND | ND | ND |
C2611A | 1 | 0.5 | 0.03 | 0.06 | ND | 0.03 | ND | ND | ND | 0.06 | 1 | ND | 1 | 0.125 |
Adapted from Bébéar et al. (2011), Cao et al. (2010), Zhao et al. (2013b), Matsuda et al. (2013), Yamazaki et al. (2007), Pereyre et al (2004b), Waites et al. (2011), Morozumi et al. (2010).
ERY, erythromycin; CLA, clarithromycin; AZM, azithromycin; JOS, josamycin; MDM, midecamycin; RKI, rokitamycin; LIN, lincomycin; CLI, clindamycin; S.C., Streptogramin combination, Q-D, quinupristin-dalfopristin; TEL, telithromycin; MIN, minocycline; CIP, ciprofloxacin; LEV, levofloxacin; MXF, moxifloxacin.
E. coli numbering.
ND, not determined.